Protein FDR Confidence: CombinedAccessionDescriptionExp. q-value: CombinedSum PEP ScoreCoverage [%]# Peptides# PSMs# Unique Peptides# AAsMW [kDa]calc. pIAbundance Ratio: (DKO) / (WT)Abundance Ratio: (SKO) / (WT)Abundance Ratio (log2): (DKO) / (WT)Abundance Ratio (log2): (SKO) / (WT)Abundance Ratio P-Value: (DKO) / (WT)Abundance Ratio P-Value: (SKO) / (WT)Abundance Ratio Adj. P-Value: (DKO) / (WT)Abundance Ratio Adj. P-Value: (SKO) / (WT)Abundances (Grouped): DKOAbundances (Grouped): SKOAbundances (Grouped): WTAbundances (Grouped) CV [%]: DKOAbundances (Grouped) CV [%]: SKOAbundances (Grouped) CV [%]: WTAbundances (Scaled): F1: 127C, Sample, DKO, 1Abundances (Scaled): F1: 128C, Sample, DKO, 2Abundances (Scaled): F1: 129C, Sample, DKO, 3Abundances (Scaled): F1: 130C, Sample, DKO, 4Abundances (Scaled): F1: 129N, Sample, SKO, 1Abundances (Scaled): F1: 130N, Sample, SKO, 2Abundances (Scaled): F1: 131, Sample, SKO, 3Abundances (Scaled): F1: 126, Sample, WT, 1Abundances (Scaled): F1: 127N, Sample, WT, 2Abundances (Scaled): F1: 128N, Sample, WT, 3Abundances (Normalized): F1: 127C, Sample, DKO, 1Abundances (Normalized): F1: 128C, Sample, DKO, 2Abundances (Normalized): F1: 129C, Sample, DKO, 3Abundances (Normalized): F1: 130C, Sample, DKO, 4Abundances (Normalized): F1: 129N, Sample, SKO, 1Abundances (Normalized): F1: 130N, Sample, SKO, 2Abundances (Normalized): F1: 131, Sample, SKO, 3Abundances (Normalized): F1: 126, Sample, WT, 1Abundances (Normalized): F1: 127N, Sample, WT, 2Abundances (Normalized): F1: 128N, Sample, WT, 3Abundance: F1: 127C, Sample, DKO, 1Abundance: F1: 128C, Sample, DKO, 2Abundance: F1: 129C, Sample, DKO, 3Abundance: F1: 130C, Sample, DKO, 4Abundance: F1: 129N, Sample, SKO, 1Abundance: F1: 130N, Sample, SKO, 2Abundance: F1: 131, Sample, SKO, 3Abundance: F1: 126, Sample, WT, 1Abundance: F1: 127N, Sample, WT, 2Abundance: F1: 128N, Sample, WT, 3Abundances Count: F1: 127C, Sample, DKO, 1Abundances Count: F1: 128C, Sample, DKO, 2Abundances Count: F1: 129C, Sample, DKO, 3Abundances Count: F1: 130C, Sample, DKO, 4Abundances Count: F1: 129N, Sample, SKO, 1Abundances Count: F1: 130N, Sample, SKO, 2Abundances Count: F1: 131, Sample, SKO, 3Abundances Count: F1: 126, Sample, WT, 1Abundances Count: F1: 127N, Sample, WT, 2Abundances Count: F1: 128N, Sample, WT, 3Biological ProcessCellular ComponentMolecular FunctionPfam IDsEntrez Gene IDGene SymbolChromosomeReactome PathwaysEnsembl Gene IDKEGG PathwaysWikiPathways# Razor PeptidesModifications
HighQ6PD03Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform OS=Mus musculus OX=10090 GN=Ppp2r5a PE=1 SV=1061.4762913181348656.37.030.330.588-1.6-0.770.065553520.011146520.5642852730.19364831151.692156.42.6921.2711.5158.256.854.556.3115.774.9100.8171.3139.5172292285273.6282.5580.5375.7505.6859.2700862.9227.4245.3243.7244.3542.1306505.6785.3616.9795.98888888888regulation of biological process;response to stimuluschromosome;cytoplasm;cytosol;membrane;nucleusenzyme regulator activity;protein bindingPf01603226849Ppp2r5a1"Beta-catenin phosphorylation cascade; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; CTLA4 inhibitory signaling; RAF activation; Interleukin-20 family signaling; Disassembly of the destruction complex and recruitment of AXIN to the membrane; Negative regulation of MAPK pathway; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal; Resolution of Sister Chromatid Cohesion; Separation of Sister Chromatids; RHO GTPases Activate Formins"ENSMUSG00000026626.11mRNA surveillance pathway; Dopaminergic synapse; Oocyte meiosis; Sphingolipid signaling pathway; PI3K-Akt signaling pathway; AMPK signaling pathway; Adrenergic signaling in cardiomyocytesFocal Adhesion-PI3K-Akt-mTOR-signaling pathway; Glycogen Metabolism; IL-6 signaling Pathway0

[View entry in the full dataset]